60 related articles for article (PubMed ID: 403421)
21. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
22. Supervised exercise training for intermittent claudication: lasting benefit at three years.
Ratliff DA; Puttick M; Libertiny G; Hicks RC; Earby LE; Richards T
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):322-6. PubMed ID: 17587612
[TBL] [Abstract][Full Text] [Related]
23. Walking exercise in patients with intermittent claudication. Experience in routine clinical practice.
Bartelink ML; Stoffers HE; Biesheuvel CJ; Hoes AW
Br J Gen Pract; 2004 Mar; 54(500):196-200. PubMed ID: 15006125
[TBL] [Abstract][Full Text] [Related]
24. [Results of the physiotherapy of arterial disease at the stage of intermittent claudication by programmed efforts training (author's transl)].
Franco A; Legrand E; Guidicelli H; Quesada C; Sarrazin R; Gautier R
J Mal Vasc; 1980; 5(3):185-9. PubMed ID: 7462850
[TBL] [Abstract][Full Text] [Related]
25. Peripheral arterial insufficiency, effect of physical training on walking tolerance, calf blood flow, and blood flow resistance.
Dahllöf AG; Holm J; Scherstén T; Sivertsson R
Scand J Rehabil Med; 1976; 8(1):. PubMed ID: 935836
[TBL] [Abstract][Full Text] [Related]
26. Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?
Leone A; Laudani R; Definite G; Martini R; Andreozzi GM
Minerva Cardioangiol; 2009 Apr; 57(2):165-74. PubMed ID: 19274027
[TBL] [Abstract][Full Text] [Related]
27. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
28. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
29. Success of an outpatient claudication group training program for patients with peripheral arterial occlusive disease (PAOD): the Tübingen model.
Klyscz T; Jünger M; Jünger I; Hahn M; Rassner G
Cent Eur J Public Health; 1997 Mar; 5(1):13-20. PubMed ID: 9150999
[TBL] [Abstract][Full Text] [Related]
30. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease.
Wang J; Zhou S; Bronks R; Graham J; Myers S
Clin Rehabil; 2007 Jul; 21(7):579-86. PubMed ID: 17702699
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
32. The Baltimore activity scale for intermittent claudication: a validation study.
Gardner AW; Montgomery PS
Vasc Endovascular Surg; 2006; 40(5):383-91. PubMed ID: 17038572
[TBL] [Abstract][Full Text] [Related]
33. Medical treatment in intermittent claudication.
Verhaeghe R; Verstraete M
Acta Cardiol; 1979; 34(3):153-61. PubMed ID: 315684
[TBL] [Abstract][Full Text] [Related]
34. Treatment of intermittent claudication.
Karthikeyan G; Eikelboom JW
BMJ; 2009 Mar; 338():b46. PubMed ID: 19289412
[No Abstract] [Full Text] [Related]
35. A comparison of placebo and heparin treatment in intermittent claudication.
NEWMAN HC; BARNETT AJ
Australas Ann Med; 1955 Aug; 4(3):195-9. PubMed ID: 13269338
[No Abstract] [Full Text] [Related]
36. [Effect of interval training for length of walk, hemodynamics and ventilation in patients with intermittent claudication. 1. Change in the length of walk].
Maass U; Cachovan M; Alexander K
Vasa; 1982; 11(2):91-6. PubMed ID: 7113419
[No Abstract] [Full Text] [Related]
37. The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol).
Haeger K
Vasc Dis; 1968 Dec; 5(4):199-213. PubMed ID: 4177853
[No Abstract] [Full Text] [Related]
38. Effect of daily muscular exercise in patients with intermittent claudication.
Larsen OA; Lassen NA
Lancet; 1966 Nov; 2(7473):1093-6. PubMed ID: 4162526
[No Abstract] [Full Text] [Related]
39. An evaluation of the various peripheral dilators used in the treatment of intermittent claudication.
GILLHESPY RO
Br J Clin Pract; 1959 Sep; 13():608-11. PubMed ID: 13848352
[No Abstract] [Full Text] [Related]
40. [The clinical use of 2 long-acting vasodilators in intermittent claudication].
CARDENAS M; OVSEIOVICH A; ROSAS BRAVO JL; FIGUEROA G; MENDEZ L; ZAJARIAS S
Arch Inst Cardiol Mex; 1962; 32():149-59. PubMed ID: 13876502
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
